Cargando...

Lichenoid drug eruption due to imatinib mesylate

Imatinib mesylate is a selective tyrosinase kinase inhibitor which has revolutionized the treatment of chronic myeloid leukemia. It is also used in gastrointestinal stromal tumors and dermatofibrosarcoma protruberans. Cutaneous adverse reactions are the most common nonhematological side effects seco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Appl Basic Med Res
Main Authors: Bhatia, Anuradha, Kanish, Bimal, Chaudhary, Paulina
Formato: Artigo
Idioma:Inglês
Publicado: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318107/
https://ncbi.nlm.nih.gov/pubmed/25664274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149253
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!